Drugs / DHA
last change May 2019 re-read 3 minutes ago

DHA

Developed for
cognitive disorder
Investigated by
Carol Fabian, MD · dsm-firmenich Switzerland AG

Trials 1

201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 0 NCT02517502 Jul 2015 → Sep 2017 cognitive disorder Carol Fabian, MD Completed No outcome recorded

Evidence & citations 1 cited value

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as DHA ClinicalTrials.gov intervention name — accepted as the source's own label NCT02517502 ↗